Skip to main content
. 2018 Apr;188(4):981–994. doi: 10.1016/j.ajpath.2017.12.016

Figure 4.

Figure 4

Selective histone deacetylase 6 (HDAC6) inhibitor, ACY-1215, shows enhanced efficacy in suppressing cyst growth in polycystic kidney (PCK) rats. A and B: ACY-1215 decreases hepatic (A) and renal (B) cystic and fibrotic areas to a higher extent than panobinostat, ACY-241 and ACY-748. Data are expressed as means ± SD. P < 0.05.